Trial intelligence / Profile preview

PK/PD of Rinsulin R vs Humulin Regular in Healthy Volunteers

NCT06050343Phase 1Completed

Sponsor
Geropharm
Start
Feb 2018
Primary completion
May 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of rinsulin r in diabetes mellitus (DM) (2 arms), sponsored by Geropharm. Primary endpoints: Maximum Concentration, Area Under the Curve 0-10h and 2 more. Started Feb 2018; status: completed.

02

Drugs

rinsulin r
03

Conditions

diabetes mellitus (DM)

Beyond the preview

Go deeper on NCT06050343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06050343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call